Frankfurt - Delayed Quote EUR
IGM Biosciences, Inc. (1K0.F)
1.0100
+0.0250
+(2.54%)
As of 8:31:16 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 4 |
Avg. Estimate | -- | -- | 499k | 1.82M |
Low Estimate | -- | -- | 499k | -- |
High Estimate | -- | -- | 499k | 4.29M |
Year Ago Sales | 1.25M | 516k | 2.68M | 499k |
Sales Growth (year/est) | -100.00% | -100.00% | -81.37% | 265.23% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
1K0.F | -- | -- | -- | -- |
S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Upgrades & Downgrades
Upgrade | JP Morgan: Underweight to Neutral | 1/13/2025 |
Downgrade | Jefferies: Buy to Hold | 1/10/2025 |
Maintains | Truist Securities: Hold to Hold | 1/10/2025 |
Downgrade | Stifel: Buy to Hold | 1/10/2025 |
Downgrade | RBC Capital: Outperform to Sector Perform | 1/10/2025 |
Downgrade | BMO Capital: Outperform to Market Perform | 1/10/2025 |
Related Tickers
HVE.F Innoviva, Inc.
15.90
-1.24%
6OP.F OSE Immunotherapeutics SA
5.98
-0.75%
UCBJY UCB SA
85.76
-0.24%
THRD Third Harmonic Bio, Inc.
5.15
0.00%
SRZN Surrozen, Inc.
6.50
-9.72%
ORKA Oruka Therapeutics, Inc.
9.71
+0.94%
ABVX ABIVAX Société Anonyme
6.10
+0.99%
ZURA Zura Bio Limited
1.1700
-3.31%
KRON Kronos Bio, Inc.
0.7250
-0.21%
FBRX Forte Biosciences, Inc.
7.60
+10.47%